Paeonol Pretreatment Attenuates Anoxia-Reoxygenation Induced Injury in Cardiac Myocytes via a BRCA1 Dependent Pathway.

Zheng, Jifeng; Mao, Zhiyao; Zhang, Jianqin; Jiang, Liqing; Wang, Ningfu

Zheng, Jifeng; Mao, Zhiyao; Zhang, Jianqin; Jiang, Liqing; Wang, Ningfu.

Afiliación

Zheng J; Department of Cardiology, The Affiliated Hangzhou Hospital of Nanjing Medical University, Hangzhou First People's Hospital.
Mao Z; Department of Cardiology, The Affiliated Second Hospital of Jiaxing Medical University.
Zhang J; Department of Cardiology, The Affiliated Second Hospital of Jiaxing Medical University.
Jiang L; Department of Cardiology, The Affiliated Second Hospital of Jiaxing Medical University.
Wang N; Department of Cardiology, The Affiliated Second Hospital of Jiaxing Medical University.

Chem Pharm Bull (Tokyo) ; 68(12): 1163-1169, 2020.

Article en En | MEDLINE | ID: mdl-33268648

Asunto(s)

Acetofenonas/farmacología; Proteína BRCA1/metabolismo; Hipoxia/tratamiento farmacológico; Miocitos Cardíacos/efectos de los fármacos; Proteína BRCA1/antagonistas & inhibidores; Supervivencia Celular/efectos de los fármacos; Células Cultivadas; Relación Dosis-Respuesta a Droga; Humanos; Hipoxia/metabolismo; Estructura Molecular; Miocitos Cardíacos/metabolismo; Miocitos Cardíacos/patología; Oxígeno/metabolismo; ARN Interferente Pequeño; Relación Estructura-Actividad

Palabras clave

Nod-like receptor protein 3 (NLRP3) inflammasome; anoxia-reoxygenation injury; breast cancer type 1 sensitive protein (BRCA1); nuclear factor-kappaB (NF-κB); paeonol; reactive oxygen species

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Acetofenonas / Proteína BRCA1 / Miocitos Cardíacos / Hipoxia Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2020 Tipo del documento: Article Pais de publicación: Japón

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google